Gardner SD, Field AM, Coleman DV, Hulme B (1971) New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1:1253–1257. https://doi.org/10.1016/s0140-6736(71)91776-4
Article CAS PubMed Google Scholar
Jamboti JS (2016) BK virus nephropathy in renal transplant recipients. Nephrology (Carlton) 21:647–654. https://doi.org/10.1111/nep.12728
Ramos E, Drachenberg CB, Wali R, Hirsch HH (2009) The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 87:621–630. https://doi.org/10.1097/TP.0b013e318197c17d
Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E (2003) Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71:115–123. https://doi.org/10.1002/jmv.10450
Ginevri F, Azzi A, Hirsch HH, Basso S, Fontana I, Cioni M, Bodaghi S, Salotti V, Rinieri A, Botti G, Perfumo F, Locatelli F, Comoli P (2007) Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 7:2727–2735. https://doi.org/10.1111/j.1600-6143.2007.01984.x
Article CAS PubMed Google Scholar
Haysom L, Rosenberg AR, Kainer G, Waliuzzaman ZM, Roberts J, Rawlinson WD, Mackie FE (2004) BK viral infection in an Australian pediatric renal transplant population. Pediatr Transplant 8:480–484. https://doi.org/10.1111/j.1399-3046.2004.00154.x
Article CAS PubMed Google Scholar
McCaffrey J, Bhute VJ, Shenoy M (2021) BK virus infection and outcome following kidney transplantation in childhood. Sci Rep 11:2468. https://doi.org/10.1038/s41598-021-82160-0
Article CAS PubMed PubMed Central Google Scholar
Costa C, Cavallo R (2012) Polyomavirus-associated nephropathy. World J Transplant 2:84–94. https://doi.org/10.5500/wjt.v2.i6.84
Article PubMed PubMed Central Google Scholar
Lee BT, Gabardi S, Grafals M, Hofmann RM, Akalin E, Aljanabi A, Mandelbrot DA, Adey DB, Heher E, Fan PY, Conte S, Dyer-Ward C, Chandraker A (2014) Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol 9:583–589. https://doi.org/10.2215/cjn.04230413
Article PubMed PubMed Central Google Scholar
Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA (2010) Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation 89:1057–1070. https://doi.org/10.1097/TP.0b013e3181d0e15e
Gras J, Le Flecher A, Dupont A, Verine J, Amara A, Delaugerre C, Molina JM, Peraldi MN (2023) Characteristics, risk factors and outcome of BKV nephropathy in kidney transplant recipients: a case-control study. BMC Infect Dis 23:74. https://doi.org/10.1186/s12879-023-08043-z
Article PubMed PubMed Central Google Scholar
Zhao W, Zhu Y (2022) Immunosuppressive management of pediatric kidney transplant recipients. Organ Transplantation 13:283–287. https://doi.org/10.3969/j.issn.1674-7445.2022.03.001
Yap HK, Teo Sharon, Ng KH (2018) Pediatric nephrology: On the go, 4th edn. Singapore
Chinese Society of Organ Transplantation (2019) BK virus infection and BK viral nephropathy in organ transplant recipients (2019 edition). Organ Transpl 10:237–242
Höcker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B, Oh J, Zirngibl M, Dello Strologo L, Büscher A, Weber LT, Awan A, Pohl M, Bald M, Printza N, Rusai K, Peruzzi L, Topaloglu R, Fichtner A, Krupka K, Köster L, Bruckner T, Schnitzler P, Hirsch HH, Tönshoff B (2019) Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN registry study. Transplantation 103:1224–1233. https://doi.org/10.1097/tp.0000000000002414
Kwon Y, Kim JY, Lee Y, Cho H (2019) Clinical manifestations of BK virus infection in pediatric kidney transplant patients. Korean J Pediatr 62:422–427. https://doi.org/10.3345/kjp.2019.00388
Article CAS PubMed PubMed Central Google Scholar
Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA (2007) BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2:1037–1042. https://doi.org/10.2215/cjn.04051206
Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, Steiger J (2002) Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347:488–496. https://doi.org/10.1056/NEJMoa020439
Schmidt T, Adam C, Hirsch HH, Janssen MW, Wolf M, Dirks J, Kardas P, Ahlenstiel-Grunow T, Pape L, Rohrer T, Fliser D, Sester M, Sester U (2014) BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication. Am J Transplant 14:1334–1345. https://doi.org/10.1111/ajt.12689
Article CAS PubMed Google Scholar
Levi S, Davidovits M, Alfandari H, Dagan A, Borovitz Y, Bilavsky E, Landau D, Haskin O (2022) EBV, CMV, and BK viral infections in pediatric kidney transplantation: frequency, risk factors, treatment, and outcomes. Pediatr Transplant 26:e14199. https://doi.org/10.1111/petr.14199
Article CAS PubMed Google Scholar
Schoephoerster J, Jensen C, Jackson S, Plautz E, Balani S, Kouri A, Kizilbash SJ (2023) BK DNAemia in pediatric kidney transplant recipients: predictors and outcomes. Pediatr Transplant 27:e14372. https://doi.org/10.1111/petr.14372
Article CAS PubMed Google Scholar
Voigt S, Schaffrath Rosario A, Mankertz A (2016) Cytomegalovirus seroprevalence among children and adolescents in Germany: data from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), 2003–2006. Open Forum Infect Dis 3:ofv193. https://doi.org/10.1093/ofid/ofv193
Popik W, Khatua AK, Fabre NF, Hildreth JEK, Alcendor DJ (2019) BK virus replication in the glomerular vascular unit: implications for BK virus associated nephropathy. Viruses 11:583. https://doi.org/10.3390/v11070583
Article CAS PubMed PubMed Central Google Scholar
Demey B, Tinez C, François C, Helle F, Choukroun G, Duverlie G, Castelain S, Brochot E (2018) Risk factors for BK virus viremia and nephropathy after kidney transplantation: a systematic review. J Clin Virol 109:6–12. https://doi.org/10.1016/j.jcv.2018.10.002
Patel H, Rodig N, Agrawal N, Cardarelli F (2021) Incidence and risk factors of kidney allograft loss due to BK nephropathy in the pediatric population: a retrospective analysis of the UNOS/OPTN database. Pediatr Transplant 25:e13927. https://doi.org/10.1111/petr.13927
Article CAS PubMed Google Scholar
Avcı B, Baskın E, Gülleroğlu K, Ecevit Z, Ayvazoğlu Soy E, Moray G, Haberal M (2022) BK polyomavirus infection and risk factors in pediatric patients undergoing kidney transplant. Exp Clin Transplant 20:105–111. https://doi.org/10.6002/ect.PediatricSymp2022.O34
Ahlenstiel-Grunow T, Pape L (2020) Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation. Pediatr Nephrol 35:375–382. https://doi.org/10.1007/s00467-018-4164-3
Jung YH, Moon KC, Ha JW, Kim SJ, Ha IS, Cheong HI, Kang HG (2013) Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation. Pediatr Transplant 17:E50-54. https://doi.org/10.1111/petr.12029
Saleh A, El Din Khedr MS, Ezzat A, Takou A, Halawa A (2020) Update on the management of BK virus infection. Exp Clin Transplant 18:659–670. https://doi.org/10.6002/ect.2019.0254
Mani J, Jin N, Schmitt M (2014) Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation. Cytotherapy 16:1325–1335. https://doi.org/10.1016/j.jcyt.2014.04.003
Comments (0)